Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D1NC2O
|
|||
| Drug Name |
Ifx-Hu2.0
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Cutaneous squamous cell carcinoma [ICD-11: 2C30] | Phase 1 | [1] | |
| Merkel cell carcinoma [ICD-11: 2C34; ICD-10: C44] | Phase 1 | [1] | ||
| Company |
Morphogenesis
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04160065) Immunotherapy With IFx-Hu2.0 Vaccine for Advanced MCC or cSCC. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.